92 GIGA 2021 Annual Report PRIORITY FILING 5 new patent applications on research findings from GIGA were filed. These patent applications are not yet published as publication usually takes place 18 months after priority filing date. GRANTED PATENTS Cyclodextrin and budesonide derivative compositions and methods (Maes P, Cataldo D, Evrard B, Dufour G, De Tullio P), priority. filing date: 28 March 2014 Patents granted in Bolivia, Singapore, Ukraine and Taiwan, ref. BOSP0052-2015, TWI725935, SG11201608075V, UA5315/ZA/21 Method for the diagnosis of airway disease inflammatory subtype (Schleich F, Louis R, Bessonov K, Van Steen K, Schooten FJ, Dallinga J), prior. filing date: 21 Sept. 2015 Patent granted in Europe (validated in France, Germany, Great Britain), ref. EP3337398B1 Method of early diagnosis of immune-mediated inflammatory disease (Malaise M, De Seny D), prior. filing date: 2 July 2016 Patents granted in USA and in Europe (validated in Belgium, France, Great Britain, Germany), ref. EP3479120B1, US11047856B2 New use of triazolo (4,5-D) pyrimidine derivatives for prevention and treatment of bacterial infection (Oury C, Lancellotti P), prior. filing date : 9 Sept. 2016 Patent granted in Australia, ref. AU2017324655 Cyclodextrine utilisée dans le traitement et la prévention de la bronchoconstriction en phase tardive de l’asthme provoqué par des allergènes (Cataldo D, Evrard B), prior. filing date : 15 June 2020 Patent granted in Belgium, ref. BE1028268 B1 PUBLISHED PATENT DOCUMENTS Portable urination weight measurement device (Jouret F, Bihr D, Niclaes C), prior. filing date: 9 June 2017 ref. US2021077007A1 Non-destructive sampling device for extraction of a marker (Castronovo V, Emmerechts C), prior. filing date: 6 Sept 2017 ref. EP3679374B1, US2021072127A1 New use of a triazolo pyrimidine derivatives for prevention and treatment of bacterial infections (Lancellotti P, Oury C, Pirotte B), prior. filing date: 14 Febr 2018 ref. US2021061804A1 Methods Involving Nucleic Acid Analysis of Milk (Michel Georges, Wouter Coppieters, Latifa Karim), prior. Filing date: 26 March 2018 ref. BR112020019306A2, JP2021519075A, EP3775279A1, US2021024995A1 Agonist of human kisspeptin receptor for modulating sexual desire (Bakker J, Ouerdi S), prior. filing date : 24 Jan 2019 ref. EP3914278 A1 New pyrimidine derivatives for prevention and treatment of gram-negative bacterial infection, contamination and fouling (Lancellotti P, Oury C, Pirotte B, Musumeci L, Jacques N, Goffin E), prior. filing date: 18 Apr 2019 ; 26 Jul 2019 ref. CN113329753A, US2021290625A1, CN113677684A, WO2021013903A1 Pooled CRISPR Inverse PCR sequencing (PCIP-SEQ): Simultaneous sequencing of viral insertion points and the integrated viral genomes with long reads (Durkin K, Artesi M, Van Den Broeke A, Bours V, Hahaut V, Georges M), prior. filing date: 3 Dec 2019 ref. WO2021110878A1 Methods and tools for analysing the Duchene Muscular Dystrophy (DMD) Gene (Beckers P, Boemer P, Servais L, Bours V), prior. filing date: 25 March 2020 ref. WO2021191386A1 Anti-CD38 single-domain antibodies in disease monitoring and treatment (Caers J, Duray E, Dumoulin M, D’Huyvetter M), prior. filing date: 15 May 2020 ref. WO2021229104A1 GIGA-BUSINESS PATENTS
RkJQdWJsaXNoZXIy MTk1ODY=